An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.
about
Surgical management of oligometastatic non-small cell lung cancerA critical review of recent developments in radiotherapy for non-small cell lung cancerStereotactic radiotherapy for early lung cancer: Evidence-based approach and future directionsThe role of local ablative therapy in oligometastatic non-small-cell lung cancer: hype or hope.Accelerated radiotherapy and concurrent chemotherapy for patients with contralateral central or mediastinal lung cancer relapse after pneumonectomyThe biology and treatment of oligometastatic cancer.Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas.Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer.Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.Ablative Therapies in Metastatic Breast Cancer: A Systematic Review.SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015.Radical thoracic radiotherapy may provide favorable outcomes for stage IV non-small cell lung cancerClinical applications of stereotactic radiation therapy for oligometastatic cancer patients: a disease-oriented approach.Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: a single-center experience and review of the literatureLung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry's experience.Surgical treatment in non-small cell lung cancer with pulmonary oligometastasisOligometastatic non-small-cell lung cancer: current treatment strategies.Should aggressive thoracic therapy be performed in patients with synchronous oligometastatic non-small cell lung cancer? A meta-analysisRadiation therapy for oligometastatic non-small cell lung cancer.The Role of Thoracic Surgery in the Therapeutic Management of Metastatic Non-small Cell Lung Cancer.The evolving role of radiotherapy in treatment of oligometastatic NSCLC.Risk factors and management of oligometastatic non-small cell lung cancer.Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung CancerStereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.Specific KRAS amino acid substitutions and EGFR mutations predict site-specific recurrence and metastasis following non-small-cell lung cancer surgery.Radiotherapy for Oligometastatic Lung Cancer.Is there a benefit to locally consolidative therapy for oligometastatic non-small cell lung cancer?How aggressive one need to be in treatment of patients with oligometastasis from non-small cell lung cancer?Role of consolidative stereotactic ablative radiotherapy in patients with oligometastatic non-small cell lung cancer.Local thoracic therapy improve prognosis for stage IV non-small cell lung cancer patients combined with chemotherapy: A Surveillance, Epidemiology, and End Results database analysis.Brain metastasis from melanoma: the prognostic value of varying sites of extracranial disease.Can urologists introduce the concept of "oligometastasis" for metastatic bladder cancer after total cystectomy?Multimodality Treatment of Advanced Non-small Cell Lung Cancer: Where are we with the Evidence?Immunomethylomics: A Novel Cancer Risk Prediction Tool.Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis.Consolidative ablative radiotherapy improves outcomes in oligometastatic non-small cell lung cancer: a further step toward new evidence.Long-term survival without surgery in NSCLC patients with synchronous brain oligometastasis: systemic chemotherapy revisited.Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.Surgical approach in oligometastatic non-small cell lung cancer.Combining radiation plus immunotherapy to improve systemic immune response.
P2860
Q28067370-706D8FE1-D29E-436E-B6BB-E03528F1A985Q28079625-8D56C08E-D92B-4FF3-AD01-49BAA3D59B1AQ28085744-DACBD74B-1B17-4FC9-A801-928EAE5E0B2DQ30248748-033243CB-FCF5-4B34-B2C4-13FC6FAFB3A1Q35290831-DEBCC9F1-00B5-4B6B-92E3-C9430E117EC3Q35832153-EF2D5BB4-F563-44D5-9DEF-219E7B3D8E01Q35954065-AC72DF19-6F6D-412E-973F-620C7D590985Q36038600-63A8F20E-8805-4B2D-A0D5-EF0B23D19CB3Q36108082-9AF9CFE0-9022-4323-A841-1E69DBB24F27Q36344204-9CB18C51-D8AD-49EF-8C7A-7E7466FEC0BBQ36400216-3FE1267D-FB76-47CC-82D7-A25DF1B64447Q36636810-17427B4B-C36B-4591-929F-C651E1272BB3Q37187233-BD9620FE-D313-486C-B31C-D44BEF78CB9AQ37584420-BC48E9E3-AC02-422B-B6DB-CD028B76A33EQ37618671-A448B270-6357-4307-8FB6-98D497B88885Q37620819-B0E985E5-C842-4DCF-B707-D323D1555F6FQ37643566-E2DE8A03-4627-4C0F-9003-ABD66E770A40Q37677637-01EFA08C-6E4A-4316-9EDC-FA6D0452FE65Q38463103-B90DE80D-BBF0-4955-B5A2-255D8DD13514Q38607262-A5D5176F-EDB3-4DE8-91D8-04E0043E785AQ38625125-111583D1-1DDA-4F06-B0E3-01CEC80E3042Q38802618-5D6A83D1-DD43-44AF-809B-D1998FA1C37EQ38880324-66ED4FC4-F4B2-4088-845A-2B8B64CDB9E2Q39051290-8B8C6386-101D-4770-B256-A0CC01286AADQ39660590-E0925552-A491-4AEF-A89E-CF3BCFD4634DQ42109226-C5944A35-C447-49FB-8C6B-8A6882999B84Q42314906-D5263BC1-942B-4F28-A244-7A49C329C914Q42354906-E24E0101-F9E5-41F0-A806-17D8734477DEQ42357374-36183377-F766-494A-A9CF-CAAF68922E57Q44772308-D104EDF5-3E09-4599-8646-103ED0D9564DQ48011082-DFF31A72-14E7-4000-8A2C-CAAA6CCD07C4Q49235556-84776134-4BB9-4778-B39D-14CB45964E28Q49773079-F975DA12-633B-43C7-8327-F9714FDE1143Q52574828-36CC3C07-E84A-48E6-BAE9-1E5A5992534EQ52591818-F569BD9F-166A-4CCD-9A75-4B1BFB741349Q52614507-91578A63-9C8F-4427-BE38-7AEBA5DB032BQ52715757-AA6B2B55-25A6-446F-B7CA-FEC93178E20DQ53045959-3AE43004-1ECA-4565-8646-0DABAF44A0A1Q55049029-68325F7D-77FE-412C-9CCF-C4D56BE04155Q55235684-1F4C960B-EDA0-496D-9997-FF289A900980
P2860
An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
An individual patient data met ...... ic non-small-cell lung cancer.
@ast
An individual patient data met ...... ic non-small-cell lung cancer.
@en
type
label
An individual patient data met ...... ic non-small-cell lung cancer.
@ast
An individual patient data met ...... ic non-small-cell lung cancer.
@en
prefLabel
An individual patient data met ...... ic non-small-cell lung cancer.
@ast
An individual patient data met ...... ic non-small-cell lung cancer.
@en
P2093
P50
P1433
P1476
An individual patient data met ...... tic non-small-cell lung cancer
@en
P2093
Allison B Ashworth
Andrew J Warner
Daniel R Gomez
David A Palma
Dennis L Carter
George B Rodrigues
Giulio Melloni
Marc Riquet
Michael T Milano
Tommaso M De Pas
P304
P356
10.1016/J.CLLC.2014.04.003
P407
P577
2014-05-15T00:00:00Z